PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
07-Jan-2020 Synthetic Biologics Receives FDA Guidance at Type C Meeting for SYN-004 (ribaxamase) Phase 1b/2a Clinical Trial in Allogeneic HCT Recipients Synthetic Biologics, Inc.
07-Jan-2020 Cellect Biotechnology Strengthens IP Portfolio; Receives "Intention to Grant" Patents from European and Israeli Patent Offices Cellect Biotechnology Ltd.
07-Jan-2020 Oncopeptides Strengthens its Regulatory Function by Appointing Karin Eklund Vanderpol as Head of Regulatory Affairs Oncopeptides AB
07-Jan-2020 Japanese Clinical Study of DiscGenics' Cell Therapy for Disc Degeneration Passes Initial Safety Review DiscGenics, Inc.
06-Jan-2020 BioNJ Announces the 2020 Innovator Award Honorees BioNJ
06-Jan-2020 Disruptive Technologies in Pharma 2020 speaker interview SMi Group Ltd
06-Jan-2020 IDEAYA Biosciences to Present at the 38th Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2020 IDEAYA Biosciences, Inc.
06-Jan-2020 United Therapeutics Corporation To Present At The 38th Annual J.P. Morgan Healthcare Conference United Therapeutics Corporation
06-Jan-2020 IDEAYA Biosciences to Present at the 38th Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2020 IDEAYA Biosciences, Inc.
06-Jan-2020 Yisheng Biopharma and Tavotek Biotherapeutics Announce Strategic Research Alliance for Development of YS-ON-001/002 and Tavo-301/303 Combination Therapy for Cancer Treatment Yisheng Biopharma Co., Ltd.
03-Jan-2020 Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Insmed Incorporated
03-Jan-2020 Halozyme Therapeutics To Present At The 38th Annual J.P. Morgan Healthcare Conference Halozyme Therapeutics, Inc.
03-Jan-2020 Just two weeks to go until SMi’s flagship Pharmaceutical Microbiology UK Conference  SMi Group
03-Jan-2020 Core One Labs' Subsidiary, Core Isogenics Inc., Completes Second and Third Harvests of Top Grade Flower at the Adelanto Indoor Grow Core One Labs Inc.
02-Jan-2020 Akcea response to draft negative guidance from NICE for WAYLIVRA▼® (volanesorsen), the only therapy for FCS, a devastating and ultra-rare disease Akcea Therapeutics
02-Jan-2020 Mirati Therapeutics To Present At The 38th Annual J.P. Morgan Healthcare Conference Mirati Therapeutics, Inc.
02-Jan-2020 Lilly to Participate in J.P. Morgan Healthcare Conference Eli Lilly and Company
02-Jan-2020 First cellularized collagen membrane implant to regenerate heart tissue in patients with ischemic heart disease 3PBiopharmaceuticals
02-Jan-2020 Pulmatrix Announces Kinase Inhibitor Licensing Agreement with Lung Cancer Initiative at Johnson & Johnson Pulmatrix, Inc.
02-Jan-2020 ORIC Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare Conference ORIC Pharmaceuticals